Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CACTUS: Cefepime/AAI101 in cUTI
NCT03680612Phase 2Completed
- Sponsor
- Allecra Therapeutics
- Start
- Sep 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of enmetazobactam in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Allecra Therapeutics. Started Sep 2017; status: completed.
02
Drugs
enmetazobactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT03680612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680612.